Baihua Pharmaceutical (600721.SH) released its first quarter financial results, with a net profit attributable to the parent company of 20.72 million yuan, a year-on-year increase of 0.28%.

The Zhitong Finance APP reported that Baohua Pharmaceutical (600721.SH) released its first quarter report for 2025. The company's first quarter operating income was 96.9172 million yuan, a year-on-year increase of 6.65%; the net profit attributable to shareholders of the listed company was 20.7209 million yuan, a year-on-year increase of 0.28%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 20.0695 million yuan, a year-on-year decrease of 0.58%; and the basic earnings per share were 0.0540 yuan/share.